Pharmaceuticals

Takeda in schizophrenia research pact with Envoy Therapeutics

09 Oct 2010

India, EU resolve dispute over generic drug seizures

08 Oct 2010

Scientists shed light on how serotonin works

06 Oct 2010

Cheek swab may detect lung cancer

06 Oct 2010

Fresenius Kabi recalls drug made by Indian arm for US sale

04 Oct 2010

Sanofi-Aventis goes hostile with $18.5-bn Genzyme bid

04 Oct 2010

Refusing to hike its offer French pharmaceutical giant Sanofi-Aventis today went hostile with its $18.5-billion takeover bid for the world's third-largest biotech firm, Genzyme Corporation

Indian scientist develops inexpensive method to isolate anti-cancer agent

04 Oct 2010

Bangalore-based Strand Life Sciences establishes subsidiary in the US

04 Oct 2010

Jubilant Life Sciences commences tender offer for Cadista Holdings Inc

01 Oct 2010

Brain chemical finding could open door to new schizophrenia drugs

01 Oct 2010

Sun Pharma receives tentative USFDA approval for generic Crestor

30 Sep 2010

Endo Pharmaceuticals to buy generic drug maker Qualitest for $1.2 billion

28 Sep 2010

GSK's diabetic drug still on sale in India as regulators dither

28 Sep 2010

Sun Pharma board approves stock split into Re1 shares

24 Sep 2010

Regulators in EU, US "kill" Glaxo’s diabetes drug Avandia

24 Sep 2010

 Doctors cannot prescribe Avandia to new patients unless they certify that they have exhausted all other remedies to control their blood sugar levels including Avandia's main competitor, Actos

Google sues rogue online pharmacies

23 Sep 2010

Abbott recalls 5 million infant formulas over beetle larvae contamination

23 Sep 2010

GSK sues Roche over Genentech's cancer drug patent infringement

23 Sep 2010

Sun acquires controlling stake in Taro, Shanghvi is chairman

22 Sep 2010

After two and a half years of legal battle, Sun's subsidiaries have increased their voting rights in Taro to 65.8 per cent

Piramal starts phase-II trials for type-2 diabetes drug

22 Sep 2010

Suven Life Sciences wins US patents for NCEs

21 Sep 2010

Boston Scientific to buy Asthmatx for $193.5 million

21 Sep 2010

Johnson & Johnson in talks to buy Crucell for $2.3 billion

17 Sep 2010

The acquisition of the Dutch vaccine maker would catapult Johnson & Johnson into the global vaccine market.

Elder Pharmaceuticals to buy UK’s NeutraHealth for Rs70.60 crore

17 Sep 2010

Forest Labs to pay more than $313 million for selling unapproved drugs

17 Sep 2010